Press Releases

Varian to Participate in UBS Virtual Global Healthcare Conference

Varian (NYSE: VAR) today announced that Dow Wilson, Chief Executive Officer, J. Michael Bruff, Chief Financial Officer, and Anshul Maheshwari, Vice President, Investor Relations and Treasurer,...

Center in Singapore Expanding Access to Radiation Therapy Technology in the Fight Against Cancer

Varian (NYSE: VAR) and the National University Cancer Institute, Singapore (NCIS), are partnering to expand access to cancer solutions in Singapore in the fight against cancer. In 2018, 26,164...

Varian Reports Results for Second Quarter of Fiscal Year 2020; Withdraws 2020 Guidance

Second Quarter 2020 Summary Oncology Systems gross orders grew 1% in dollars or 2% in constant currency in the quarter; trailing twelve months gross orders grew 5% in dollars or 6% in constant...

Varian Announces Second Quarter Fiscal Year 2020 Earnings Release Date

Varian (NYSE: VAR) today announced its second quarter fiscal year 2020 earnings release date. The Company will report results for the second quarter of fiscal year 2020 after market close on...

Varian Brings Machine Learning to Proton Treatment Planning with Eclipse v16

Highlights RapidPlan PT is the first clinical application of machine learning in proton treatment planning RT Peer Review is designed to streamline and accelerate the radiation therapy peer review...

Alabama's Only Proton Therapy Center Treats First Patient with Varian ProBeam

PALO ALTO, Calif., March 17, 2020 /PRNewswire/ -- Varian (NYSE: VAR) announced today, Proton International at UAB has now treated its first cancer patient with the Varian ProBeam® Compact proton therapy system. The center, a collaboration between…

Varian to Equip New Ethos Personalized Adaptive Therapy Center in Phoenix

Varian (NYSE: VAR) today announced it was selected to equip the new Ethos Personalized Adaptive Therapy Center in Phoenix, Arizona, and help launch a new era in cancer treatment for patients in...

Varian Halcyon 2.0 Treatment System Receives China NMPA Approval

Varian (NYSE: VAR) today announced its Halcyon™ 2.0 treatment system has been approved by the China National Medical Products Administration (NMPA), which allows the company to market this...

Quebec Selects Varian to Increase Access to Advanced Cancer Care

Varian (NYSE: VAR) today announced that the procurement representative of the Quebec government, Groupe d'Approvisionnement Commun de l'Est du Québec (GACEQ), filed a notice of intent to award a...

Ethos Therapy Continues Global Expansion

Varian (NYSE: VAR) today announced Medisch Spectrum Twente Hospital in The Netherlands, and Icon Cancer Centre Wahroonga and Royal North Shore Hospital (RNSH) in Australia treated their first...